Cardiac magnetic resonance T2* mapping in patients with COVID-19 pneumonia is associated with serum ferritin level?
- PMID: 36542216
- PMCID: PMC9768776
- DOI: 10.1007/s10554-022-02784-9
Cardiac magnetic resonance T2* mapping in patients with COVID-19 pneumonia is associated with serum ferritin level?
Abstract
The coronavirus disease of 2019 (COVID-19)-related myocardial injury is an increasingly recognized complication and cardiac magnetic resonance imaging (MRI) has become the most commonly used non-invasive imaging technique for myocardial involvement. This study aims to assess myocardial structure by T2*-mapping which is a non-invasive gold-standard imaging tool for the assessment of cardiac iron deposition in patients with COVID-19 pneumonia without significant cardiac symptoms. Twenty-five patients with COVID-19 pneumonia and 20 healthy subjects were prospectively enrolled.Cardiac volume and function parameters, myocardial native-T1, and T2*-mapping were measured. The association of serum ferritin level and myocardial mapping was analyzed. There was no difference in terms of cardiac volume and function parameters. The T2*-mapping values were lower in patients with COVID-19 compared to controls (35.37 [IQR 31.67-41.20] ms vs. 43.98 [IQR 41.97-46.88] ms; p < 0.0001), while no significant difference was found in terms of native-T1 mapping value(p = 0.701). There was a positive correlation with T2*mapping and native-T1 mapping values (r = 0.522, p = 0.007) and negative correlation with serum ferritin values (r = - 0.653, p = 0.000), while no correlation between cardiac native-T1 mapping and serum ferritin level. Negative correlation between serum ferritin level and T2*-mapping values in COVID-19 patients may provide a non-contrast-enhanced alternative to assess tissue structural changes in patients with COVID-19. T2*-mapping may provide a non-contrast-enhanced alternative to assess tissue alterations in patients with COVID-19. Adding T2*-mapping cardiac MRI in patients with myocardial pathologies would improve the revealing of underlying mechanisms. Further in vivo and ex vivo animal or human studies designed with larger patient cohorts should be planned.
Keywords: COVID-19; Cardiac magnetic resonance imaging (MRI); Ferritin; Myocarditis.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.
Conflict of interest statement
The authors have no relevant financial or non-financial interests to disclose.
Figures



Similar articles
-
Myocardial Tissue Characterization in Cardiac Magnetic Resonance Studies of Patients Recovering From COVID-19: A Meta-Analysis.J Am Heart Assoc. 2023 Mar 21;12(6):e027801. doi: 10.1161/JAHA.122.027801. Epub 2023 Mar 9. J Am Heart Assoc. 2023. PMID: 36892052 Free PMC article.
-
Observation of Myocardial Involvement in Patients Recovered From COVID-19 by Using Cardiac Magnetic Resonance Imaging, In a Tertiary Care Hospital, Bangladesh.Mymensingh Med J. 2022 Oct;31(4):1108-1114. Mymensingh Med J. 2022. PMID: 36189559
-
Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19).JAMA Cardiol. 2020 Nov 1;5(11):1265-1273. doi: 10.1001/jamacardio.2020.3557. JAMA Cardiol. 2020. PMID: 32730619 Free PMC article.
-
Recent Advances in T1 and T2 Mapping in the Assessment of Fulminant Myocarditis by Cardiac Magnetic Resonance.Curr Cardiol Rep. 2020 May 29;22(7):47. doi: 10.1007/s11886-020-01295-0. Curr Cardiol Rep. 2020. PMID: 32472218 Review.
-
Cardiac involvement in coronavirus disease 2019 assessed by cardiac magnetic resonance imaging: a meta-analysis.Heart Vessels. 2022 Sep;37(9):1570-1582. doi: 10.1007/s00380-022-02055-6. Epub 2022 Mar 16. Heart Vessels. 2022. PMID: 35294611 Free PMC article.
References
-
- World Health Organization (2020) Coronavirus disease 2019 (COVID-19) situation report-51. Available at: https://www.who.int/docs/default-source/coronaviruse/situation-reports/2.... Accessed 28 Jan 2021
-
- World Health Organization (2021) Actualización epidemiológica semanal COVID-19. World Health Organization, pp 1–3
-
- Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, Ma K, Xu D, Yu H, Wang H, Wang T, Guo W, Chen J, Ding C, Zhang X, Huang J, Han M, Li S, Luo X, Zhao J, Ning Q. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;26(368):m1091. doi: 10.1136/bmj.m1091. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical